当前位置:首页 - 行情中心 - 永安药业(002365) - 财务分析 - 现金流量表

永安药业

(002365)

  

流通市值:40.89亿  总市值:49.06亿
流通股本:2.46亿   总股本:2.95亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金604,670,318.15393,496,343.75191,168,337.1868,377,965.49
  收到的税费返还18,198,428.713,486,863.476,926,520.5628,713,253.51
  收到其他与经营活动有关的现金24,002,348.122,355,922.771,339,713.849,660,643.31
  经营活动现金流入小计646,871,094.97409,339,129.99199,434,571.5906,751,862.31
  购买商品、接受劳务支付的现金377,848,425.62253,628,438.71115,843,390.49571,567,824.89
  支付给职工以及为职工支付的现金92,699,788.5867,744,885.6642,220,940.25112,714,827.8
  支付的各项税费18,644,318.1213,397,465.246,489,998.838,844,915.91
  支付其他与经营活动有关的现金59,013,673.7723,386,789.7610,178,307.677,911,612.17
  经营活动现金流出小计548,206,206.09358,157,579.37174,732,637.14801,039,180.77
  经营活动产生的现金流量净额98,664,888.8851,181,550.6224,701,934.36105,712,681.54
二、投资活动产生的现金流量:
  收回投资收到的现金758,986,464.57380,710,244.38122,998,098.741,684,200,279.76
  取得投资收益收到的现金20,299,520.839,603,224.084,525,753.3835,305,388.44
  处置固定资产、无形资产和其他长期资产收回的现金净额8,6672,7172,7171,893,443.72
  投资活动现金流入小计779,294,652.4390,316,185.46127,526,569.121,721,399,111.92
  购建固定资产、无形资产和其他长期资产支付的现金44,045,461.5332,199,901.9520,010,736.75118,043,778.99
  投资支付的现金845,330,607.59442,121,223.62215,858,044.151,650,739,320.93
  投资活动现金流出小计889,376,069.12474,321,125.57235,868,780.91,768,783,099.92
  投资活动产生的现金流量净额-110,081,416.72-84,004,940.11-108,342,211.78-47,383,988
三、筹资活动产生的现金流量:
  取得借款收到的现金15,000,00015,000,000-40,000,000
  收到其他与筹资活动有关的现金-780,723.23-600,000
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计15,000,00015,780,723.23-40,600,000
  偿还债务支付的现金26,150,00021,000,00010,000,00010,500,000
  分配股利、利润或偿付利息支付的现金29,661,234.34495,348.64238,862.5135,816,071.86
  其中:子公司支付给少数股东的股利、利润---6,000,000
  支付其他与筹资活动有关的现金35,192,817.5416,292,817.5416,292,817.5431,683,171.45
  筹资活动现金流出小计91,004,051.8837,788,166.1826,531,680.0577,999,243.31
  筹资活动产生的现金流量净额-76,004,051.88-22,007,442.95-26,531,680.05-37,399,243.31
四、汇率变动对现金及现金等价物的影响1,850,474.491,865,228.081,418,210.485,247,639.51
五、现金及现金等价物净增加额-85,570,105.23-52,965,604.36-108,753,746.9926,177,089.74
  加:期初现金及现金等价物余额320,405,292.96320,405,292.96320,405,292.96294,228,203.22
  期末现金及现金等价物余额234,835,187.73267,439,688.6211,651,545.97320,405,292.96
补充资料:
  净利润-8,556,158.69-59,707,704.78
  资产减值准备-444,891-18,286,031.52
  固定资产和投资性房地产折旧-55,287,353.69-109,414,917.99
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-55,287,353.69-109,414,917.99
  无形资产摊销-1,729,949.17-3,416,243.2
  处置固定资产、无形资产和其他长期资产的损失--32,631.44-326,208.7
  固定资产报废损失---94,814.46
  公允价值变动损失--2,004,491.16--4,431,333.86
  财务费用--658,520.54--8,057,684.54
  投资损失--11,461,930.22--39,679,131.94
  递延所得税--3,238,406.82--16,924,772.12
  其中:递延所得税资产减少--1,763,382.57-5,418,711.22
    递延所得税负债增加--1,475,024.25--22,343,483.34
  存货的减少--7,052,303.73--25,280,041.79
  经营性应收项目的减少-31,376,196.77-36,676,919.33
  经营性应付项目的增加--20,294,174.27--28,194,407.83
  现金的期末余额-267,439,688.6-320,405,292.96
  减:现金的期初余额-320,405,292.96-294,228,203.22
  现金及现金等价物的净增加额--52,965,604.36-26,177,089.74
公告日期2025-10-302025-08-282025-04-292025-04-10
审计意见(境内)标准无保留意见
TOP↑